Investment Rating - The report maintains an "Underweight" (UW) rating for SMIC with a price target of HK$32.00 for December 2025, reflecting concerns over weak revenue guidance and gross margin pressures [1][11][35]. Core Insights - SMIC's 1Q25 revenues were below expectations, with a 5% shortfall compared to guidance, attributed to yield challenges and a decline in average selling prices (ASP) [7][11]. - The company experienced a 15% quarter-over-quarter growth in shipments, particularly in 12" wafers, driven by customer demand pull-ins and restocking in the automotive sector [1][7]. - The 2Q25 guidance indicates a revenue decline of 4-6% quarter-over-quarter, with management expressing caution regarding demand visibility beyond 3Q [1][11]. - Adjustments to revenue growth estimates for 2025 have been made, reducing the forecast from 16% to 10-11% due to a weaker outlook for the second half of the year [1][11]. Summary by Sections Financial Performance - 1Q25 revenue was reported at US$2,247.2 million, with gross margins at 22.5%, exceeding consensus estimates by 170-190 basis points [16][11]. - The adjusted net income for 2025 is revised down to US$705 million from US$788 million, while the revenue estimate is adjusted to US$8,877 million from US$9,284 million [2][24]. Quarterly Forecasts - For 2025, the quarterly forecasts show a decline in revenues for 2Q25 to between US$2,112 million and US$2,157 million, down 4-6% quarter-over-quarter [17][22]. - The gross margin for 2Q25 is expected to be between 18-20%, indicating continued pressure on profitability [17][22]. Valuation Metrics - The price target of HK$32 is based on a price-to-book ratio of approximately 1.5x, reflecting concerns over revenue and gross margin trajectories [11][36]. - The report anticipates that gross margins will remain in the range of 20-22% with return on equity (ROE) staying below 5% in the coming years [1][11].

Investment Rating - The investment rating for VNET Group Inc is Overweight [2][65] - The industry view is Attractive [2][65] Core Insights - VNET Group Inc's stock price closed at US$5.96 on May 9, 2025, with a 52-week range of US$16.13 to US$1.71 [2] - The company has a market capitalization of approximately RMB 12,524 million and an enterprise value of RMB 23,618 million [2] - Average daily trading value is US$20 million [2] Summary by Sections Data Center Electricity Usage - In April 2025, Ulanqab's datacenter electricity usage was 288 GWh, translating to an average daily power usage of 400 MW, marking a 13% month-over-month increase from March [7] - The strong electricity usage indicates robust demand in the region, with VNET's total delivery plan of 323 MW in Ulanqab for 2025 [7] REIT Approval - VNET's private REITs, valued at RMB 860 million, received official approval on May 9, which could support its capital expenditure plan of RMB 10-12 billion [7]

Investment Rating - The report indicates a positive outlook for Chinese equities, suggesting a better chance of inflow upside than downside due to measured macro and earnings drag from tariffs compared to peers [2][3]. Core Insights - The report highlights that new developments in trade talks and domestic policy easing by the PBOC and CSRC have led to a rapid shift in market dynamics, with a record-high attendance at the MS China BEST conference indicating rising investor interest in China [3][4]. - Despite potential headwinds on corporate earnings starting from Q2, the overall setup for Chinese equities remains relatively stable compared to other major economies, with a smaller magnitude of negative change expected [4][7]. - The report emphasizes that the listed Chinese equity universe is less exposed to the tariff dispute due to limited foreign revenue exposure, which is under 15% [7][9]. Summary by Sections Market Dynamics & Investor Sentiment - Investors expressed a strong willingness to diversify their asset allocation towards China, driven by a weakening US dollar and ongoing tariff uncertainties [8][9]. - The report notes that China presents the largest underweight gap within existing global EM equities, with over 80% of investors indicating plans to increase their Chinese equity exposure [9]. Macro and Corporate Earnings - The near-term impact of tariffs on macro and corporate earnings is negative but not as severe as in other major economies, with China’s GDP growth forecast revised down by 0.3 percentage points to 4.2% for 2025 [4][7]. - Earnings growth forecasts for MSCI China have been revised down from 7% to 5%, while the broader MSCI EM index forecast has been cut from 11% to 3% [4]. Policy Support and Structural Opportunities - The report discusses the potential for policy easing, with a fiscal package of RMB 2 trillion announced and a possible additional package of RMB 1-1.5 trillion in the second half of 2025, which could cushion macro growth by up to 60 basis points [7]. - There is a growing investor interest in AI, tech, and new economy sectors, indicating a shift towards new equity market champions following a period of disruption [18][19]. Trade Talks and Market Strategy - The report advises a balanced approach during the ongoing US-China trade talks, recommending high-quality, large-cap internet names and selective high-tech players while maintaining some dividend yield plays to mitigate market volatility [24][25].

Investment Rating - The industry investment rating is classified as Attractive [6]. Core Insights - More steel mills have received production control notices, indicating tighter supply conditions in the steel market [9]. - Cement and long steel products consumption were affected by holidays and rainy weather, leading to fluctuations in demand [9]. - Planned production in the lithium battery supply chain has seen a mild increase in May, reflecting ongoing investment in this sector [9]. - Total investment in projects that started construction in April was approximately Rmb 3.2 trillion, representing a decrease of 8% month-over-month and 20% year-over-year, while the year-to-date figure is up 16% year-over-year [9]. Summary by Sections Production and Sales - Jiangsu and Shaanxi provinces have been ordered to reduce their annual crude steel production by 6 million tons and 1 million tons, respectively [2]. - Daily output of crude steel from key enterprises was reported at 2.202 million tons at the end of April, showing a decrease of 1.2% compared to mid-April but a slight increase of 0.1% year-over-year [2]. Market Activity - PV retail sales reached 1.755 million units in April, marking a year-over-year increase of 14.5% but a month-over-month decline of 9.4% [3]. - NEV sales totaled 905,000 units in April, reflecting a year-over-year increase of 33.9% but a month-over-month decrease of 8.7% [3]. - Excavator sales in April were estimated at around 22,000 units, up 17% year-over-year [3]. Building Materials - Weekly cement shipments in May were reported at 175.3 billion Rmb, with North China showing a 51% share, down 3.3 percentage points year-over-year [4]. - The investment in new projects started in April was Rmb 3.2 trillion, down 8% month-over-month and 20% year-over-year [4]. Consumption Trends - Weekly steel apparent consumption was reported at 21.8 million tons year-to-date, with long products down 23% and flat products down 6% compared to the previous year [4]. - Glass inventory increased by 3% month-over-month and 6% year-over-year, indicating stable demand in the glass sector [4].

Investment Rating - The investment rating for Shenzhen Inovance Technology is Equal-weight [5] Core Insights - The automation orders in April showed high single-digit year-on-year growth, although some industries like PIMM experienced a year-on-year decline. Conversely, sectors such as battery, machine tool, logistics machinery, packaging, and air conditioners for data centers maintained solid order levels [1] - Management is optimistic about maintaining stable gross profit margins (GPM) for automation in 2025, expecting a contraction of less than 1 percentage point year-on-year in Q1 2025, with no significant adjustments in average selling prices (ASP) year-to-date [2] - The top five clients in the New Energy Vehicle (NEV) sector contributed 50-60% of total EV powertrain revenue, with Li Auto leading at 20-30% [3] Summary by Sections Automation Orders - April automation orders showed high single-digit year-on-year growth, with weaker momentum in industries like PIMM, textile, solar, 3C, and air compressors. However, demand remained solid in battery, machine tool, logistics machinery, packaging, and air conditioners for data centers [1] Gross Profit Margin - Management expects the full-year GPM for automation to remain stable compared to a decline of 2 percentage points in 2024, with Q1 2025 showing a contraction of less than 1 percentage point year-on-year [2] Client Contributions - The top five NEV clients accounted for 50-60% of total EV powertrain revenue, with Li Auto contributing 20-30%, followed by GAC and Chery. Foreign auto OEM clients contributed 5-6% in aggregate [3] Product Pipeline - Inovance plans to launch significant humanoid products in the second half of 2025, including motors, screws, and modules, and aims to introduce a collaborative robot (cobot) product for public sale soon [3]

Investment Rating - The industry investment rating is "In-Line" [4] Core Insights - Most companies in the Greater China Technology Hardware sector report no negative impact from tariffs on their operations, with several companies expressing confidence in achieving their growth targets [6][4] - The demand for servers is expected to remain strong in the domestic market, contributing positively to revenue growth [6] Company Summaries - **AAC Technologies Holdings**: The company is optimistic about achieving its full-year growth target, driven by thermal solutions and new optical breakthroughs, with expectations of continuous improvement in gross margins [1] - **BYD Electronics**: Experienced a revenue decline in its high-margin component business but is seeing strong growth in its new EV business and anticipates rapid growth in the server business due to strong domestic demand [2] - **Transsion**: The first quarter is typically a slow season for smartphone shipments, but the company expects a margin recovery, with its IoT business growing faster than smartphones, particularly due to energy storage demand in Africa [3] Stock Ratings Overview - **AAC Technologies Holdings (2018.HK)**: Overweight [57] - **BYD Electronics (0285.HK)**: Overweight [57] - **Transsion Holdings (688036.SS)**: Overweight [57] - **Sunny Optical (2382.HK)**: Equal-weight [57] - **Xiaomi Corp (1810.HK)**: Overweight [57]

Investment Rating - The report does not explicitly state an investment rating for the biotech industry but discusses various companies and their expected performance in upcoming earnings reports and FDA approvals [2][4]. Core Insights - The report highlights the upcoming Q1 earnings for pre-commercial biotech companies, emphasizing the importance of cash burn and performance metrics [2][4]. - It notes a trend of pre-commercial underperformance and a reduction in negative enterprise value (EV) stocks, suggesting a potential shift in market sentiment [2][4]. - The FDA's recent changes and their impact on drug approval timelines are discussed, with a focus on how these changes may affect interactions with the agency and overall industry sentiment [14][30]. Summary by Sections 1Q25E EPS – MS Commercial Stocks - Key companies to watch include YMAB, EXEL, and LEGN, with specific revenue and EPS expectations outlined [11]. 1Q25E EPS – Precommercial Coverage - Companies like ALEC and KYMR are highlighted for their expected EPS performance, with commentary on upcoming data readouts and trials [12]. Snap FDA Corporate Survey - A survey of 100 companies revealed that 84% anticipate no change in their interactions with the FDA, while 12% expect positive impacts from recent changes [14]. FDA Approval Timeline Tracker - A detailed tracker of upcoming FDA approvals for various drugs, including their status and expected filing dates, is provided [16]. EPIC Could Drive a Small Molecule Renaissance - The report discusses the potential for a renaissance in small molecule drugs, indicating a shift in focus within the biotech sector [28]. Biotech Stocks with Negative EV - The report screens for biotech companies trading below cash, identifying potential investment opportunities in this segment [35].

Investment Rating - The industry investment rating is "In-Line" [7] Core Insights - In April, combined sales of servo and low-voltage AC drives from four global players in China decreased by -1% and -7% respectively, compared to previous year growth rates of +1% and -1% in March 2025 [1][5] - Inovance's automation orders growth slowed to high single-digit year-on-year in April, down from approximately 30% year-on-year in March, with several industries negatively impacted by US tariffs [2] - Haitian International's April orders showed high single-digit year-on-year growth but a low single-digit month-on-month decline, with domestic orders flat year-on-year and overseas orders experiencing teens growth [3] - The manufacturing PMI in China fell to 49.0 in April from 50.5 in March, indicating a contraction in manufacturing activity [10] Summary by Sections Sales Performance - Global players' servo sales in China saw a decline of -1% year-on-year, while low-voltage AC drive sales decreased by -7% [1][5] - Inovance's orders growth decelerated to high single-digit year-on-year in April, significantly lower than the previous month's growth [2] Regional Insights - Domestic orders for general equipment remained flat year-on-year, while overseas orders posted a teens growth year-on-year [3] Market Trends - The overall automation market is beginning to feel the impact of tariff tensions, leading to a moderation in order growth for several players [10]

Investment Rating - Stock Rating: Overweight [4] - Industry View: Attractive [4] - Price Target: Rmb28.94 [4] Core Insights - LONGi expects a 10% global demand growth in 2025 under an optimistic scenario, with uncertain domestic demand in the second half of 2025 [2][7] - The company anticipates single-digit increases in Europe and the US, while robust demand is expected from emerging markets in the Middle East and India [2] - Oversupply may persist until a turning point, potentially in 4Q25 or 1Q26, as industry players navigate around profit break-even levels [2][7] - Despite mild demand and large supply, significant fluctuations in average selling prices (ASP) are not expected, indicating a more rational industry environment [2][7] - Financing channels are tightening, leading to rising financing costs across the industry [2] Summary by Sections Demand and Supply Dynamics - LONGi's cell production facility in Malaysia is capable of supplying the US market, which currently lacks solar cell supply, with anti-dumping and countervailing duty (AD/CVD) tariff rates at approximately 41% [2][7] - As of the end of 2024, LONGi acknowledged a valid cell capacity of 60GW (TOPCon and BC), with BC Gen II capacity projected to reach 50GW by the end of 2025 following capacity upgrades [2] Shipment Performance - In 1Q25, BC module shipments reached 4.3GW, driven by a rush in installations, particularly in the distributed solar sector, comprising 1.2GW of BC Gen II and 3.1GW of BC Gen I [3]

Investment Rating - The report indicates a positive shift in the US-China trade relationship, suggesting a favorable environment for investment opportunities in the Asia-Pacific region [1][2]. Core Insights - The US-China tariff de-escalation occurred more rapidly and significantly than anticipated, with a joint announcement to reverse the tit-for-tat tariff escalation and suspend 24% of the remaining reciprocal 34% hike for a 90-day period starting May 14 [1][2]. - The effective US trade-weighed tariff on China is now approximately 40%, down from 107%, which is a substantial improvement compared to previous forecasts [1][3]. - The establishment of a standing consultation mechanism between the US and China marks a shift from confrontation to managed negotiation, potentially stabilizing trade relations [2]. Summary by Sections Tariff Changes - The US has reduced headline reciprocal tariffs on China from 125% to 34%, with a 90-day suspension of 24% of the remaining hikes [8][9]. - The actual tariff path has deviated significantly from earlier assumptions, indicating a more favorable trade environment than previously expected [7][8]. Economic Implications - The tariff pause is expected to provide a temporary boost to GDP, with 2Q GDP potentially exceeding the current tracking of approximately 4.5% and 3Q GDP stabilizing above 4% [3][4]. - Despite the positive short-term outlook, a durable resolution to trade tensions remains complex due to the intricate bilateral relationship [3].